Maternal RSV vaccination and nirsevimab were associated with a reduction in RSV hospitalization rates in infants aged 0 to 7 months during the 2024-2025 RSV season.

New findings provide compelling evidence for the protective benefits of maternal RSVpreF vaccination during pregnancy.

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...

Maternal RSV vaccination and nirsevimab were associated with a reduction in hospitalization rates among infants aged 0 to 7 months.

The Kids Research Institute Australia’s latest strategy signals a pivotal shift, not just in what it aims to achieve, but how ...

The charity provided her and her former partner, Joe, with a place to stay while their son, Jaxxon, was critically ill.

The American Academy of Pediatrics has said childhood vaccines are carefully studied in randomized controlled trials — ...

The report – Prevention Pays: The Economic Value of Adult Vaccination – underscores how a nationwide publicly funded vaccination programme for influenza, shingles, and respiratory syncytial virus (RSV ...

PEMGARDA™ (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales forcePEMGARDA revenue ...

DDG responded to Bailey's claims violently, screaming profanities at her, damaging her ring camera, and attempting to take their child with him without her consent. Halle's request for a restraining ...

In documents requesting the order, Bailey alleges that there have been “multiple acts of physical violence” following their ...

Peter Gillooly, CEO of The Wellness Company, made a formal complaint to HHS' Office of the Special Counsel and other agencies ...